7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2B | $78M | 55.5% | 0.0% | $149M | $2.1B | $345M |
| 2024 | $1.1B | $44M | 54.7% | 27.0% | $45M | $2.2B | $277M |
| 2023 | $1.0B | $51M | 55.0% | 26.4% | -$363M | $2.2B | $296M |
| 2022 | $1.0B | -$234M | 55.5% | 24.7% | $96M | $1.9B | $395M |
| 2021 | $931M | $116M | 55.7% | 27.6% | $179M | $1.7B | $107M |
| 2020 | $818M | -$39M | 54.2% | 25.2% | $67M | $1.8B | $102M |
| 2019 | $778M | -$21M | 50.8% | 23.6% | $92M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $280M | $27M | 52.5% | 0.0% | -$17M | $2.1B | $314M |
| Dec '25 | $303M | $35M | 54.7% | 0.0% | $52M | $2.1B | $345M |
| Sep '25 | $311M | $48M | 57.0% | 0.0% | $35M | $2.1B | $299M |
| Jun '25 | $294M | $8M | 56.6% | 0.0% | $26M | $2.2B | $332M |
| Mar '25 | $255M | -$13M | 53.2% | 0.0% | $36M | $2.2B | $304M |
| Dec '24 | $290M | $12M | 56.6% | 30.0% | -$10M | $2.2B | $277M |
| Sep '24 | $285M | $17M | 55.4% | 28.2% | $61M | $2.2B | $307M |
| Jun '24 | $277M | $9M | 55.2% | 27.8% | $19M | $2.2B | $246M |
| Mar '24 | $248M | — | 51.2% | 21.4% | -$25M | $2.2B | $261M |
| Dec '23 | $310M | $39M | 58.0% | 33.5% | $48M | $2.2B | $296M |
| Sep '23 | $263M | -$14M | 55.5% | 28.9% | -$10M | $2.2B | $245M |
| Jun '23 | $255M | $24M | 54.7% | 24.8% | -$390M | $2.2B | $263M |
| Mar '23 | $221M | — | 50.5% | 15.1% | -$11M | $2.2B | $648M |
| Dec '22 | $252M | -$320M | 56.3% | 23.9% | $30M | $1.9B | $395M |
| Sep '22 | $249M | $25M | 54.7% | 25.4% | $29M | $1.7B | $164M |
| Jun '22 | $267M | $30M | 56.4% | 26.8% | $22M | $1.7B | $140M |
| Mar '22 | $237M | $31M | 54.4% | 22.6% | $14M | $1.8B | $121M |
| Dec '21 | $241M | $36M | 55.5% | 27.5% | $25M | $1.7B | $107M |
| Sep '21 | $226M | $27M | 55.5% | 29.0% | $65M | $1.7B | $115M |
| Jun '21 | $252M | $43M | 57.1% | 31.1% | $54M | $1.8B | $156M |
How the market has priced SHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Sotera Health Co's revenue has grown 7.3% per year. These are computed facts, not advice.
As of FY2025, Sotera Health Co reported $2.1B of total debt against $345M of cash.
In FY2025, gross margin was 55.5%, operating margin —, and net margin 6.7%.
As of Jun '26, Sotera Health Co traded at a price-to-earnings ratio of about 62.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.